Literature DB >> 11966674

A possible interaction between lithium and rofecoxib.

Jöns Lundmark, Tove Gunnarsson, Finn Bengtsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11966674      PMCID： PMC1874267          DOI： 10.1046/j.1365-2125.2002.01572_1.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  4 in total

Review 1.  Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition.

Authors:  D C Brater
Journal:  Am J Med       Date:  1999-12-13       Impact factor: 4.965

2.  Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy.

Authors:  Glen S Markowitz; Jai Radhakrishnan; Neeraja Kambham; Anthony M Valeri; William H Hines; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2000-08       Impact factor: 10.121

3.  Are selective COX-2 inhibitors nephrotoxic?

Authors:  M A Perazella; J Eras
Journal:  Am J Kidney Dis       Date:  2000-05       Impact factor: 8.860

Review 4.  Clinical relevance of drug interactions with lithium.

Authors:  P R Finley; M D Warner; C A Peabody
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447
  4 in total
  2 in total

1.  A life-threatening interaction between lithium and celecoxib.

Authors:  Lars Slørdal; Stein Samstad; Jørn Bathen; Olav Spigset
Journal:  Br J Clin Pharmacol       Date:  2003-04       Impact factor: 4.335

Review 2.  Pharmacokinetics of rofecoxib: a specific cyclo-oxygenase-2 inhibitor.

Authors:  Neal M Davies; Xiao W Teng; Neil M Skjodt
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.